159 related articles for article (PubMed ID: 12435434)
1. Hallucinogens and Drosophila: linking serotonin receptor activation to behavior.
Nichols CD; Ronesi J; Pratt W; Sanders-Bush E
Neuroscience; 2002; 115(3):979-84. PubMed ID: 12435434
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration.
Nichols CD; Garcia EE; Sanders-Bush E
Brain Res Mol Brain Res; 2003 Mar; 111(1-2):182-8. PubMed ID: 12654518
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase-1, C/EBP-beta and ILAD-1, a novel gene with homology to arrestins.
Nichols CD; Sanders-Bush E
J Neurochem; 2004 Aug; 90(3):576-84. PubMed ID: 15255935
[TBL] [Abstract][Full Text] [Related]
4. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
5. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
Sloviter RS; Drust EG; Damiano BP; Connor JD
J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
[No Abstract] [Full Text] [Related]
6. A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain.
Nichols CD; Sanders-Bush E
Neuropsychopharmacology; 2002 May; 26(5):634-42. PubMed ID: 11927188
[TBL] [Abstract][Full Text] [Related]
7. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
Gresch PJ; Strickland LV; Sanders-Bush E
Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
[TBL] [Abstract][Full Text] [Related]
8. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.
Krebs-Thomson K; Paulus MP; Geyer MA
Neuropsychopharmacology; 1998 May; 18(5):339-51. PubMed ID: 9536447
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
[TBL] [Abstract][Full Text] [Related]
10. Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
Glennon RA; Rosecrans JA
Neurosci Biobehav Rev; 1982; 6(4):489-97. PubMed ID: 6757811
[TBL] [Abstract][Full Text] [Related]
11. Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats.
Heym J; Rasmussen K; Jacobs BL
Eur J Pharmacol; 1984 May; 101(1-2):57-68. PubMed ID: 6745319
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.
Halberstadt AL
Behav Brain Res; 2015 Jan; 277():99-120. PubMed ID: 25036425
[TBL] [Abstract][Full Text] [Related]
13. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
Oelssner W
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
[No Abstract] [Full Text] [Related]
14. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.
Appel JB; White FJ; Holohean AM
Neurosci Biobehav Rev; 1982; 6(4):529-36. PubMed ID: 7177512
[TBL] [Abstract][Full Text] [Related]
15. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
16. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
[TBL] [Abstract][Full Text] [Related]
18. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains.
Ouagazzal A; Grottick AJ; Moreau J; Higgins GA
Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170
[TBL] [Abstract][Full Text] [Related]
19. Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).
Nichols DE; Frescas S; Marona-Lewicka D; Kurrasch-Orbaugh DM
J Med Chem; 2002 Sep; 45(19):4344-9. PubMed ID: 12213075
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
Helsley S; Fiorella D; Rabin RA; Winter JC
Pharmacol Biochem Behav; 1998 Feb; 59(2):419-25. PubMed ID: 9476990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
